Brief: Hutchmed (China) Says Astrazeneca Submits US NDA For Orpathys Plus Tagrisso
BRIEF-Hutchmed (China) Says Astrazeneca Submits US NDA For Orpathys Plus Tagrisso Sept 29 (Reuters) - HUTCHMED (China) Ltd 0013.HK:
ASTRAZENECA SUBMITS US NDA FOR ORPATHYS PLUS TAGRISSO IN MET-DRIVEN EGFR-MUTATED LUNG CANCER
Further company coverage: 0013.HK
((Reuters.Briefs@thomsonreuters.com;))